MHRA Drug Safety Update: February 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 7 February 2024) has been published and includes articles on: Codeine linctus (codeine oral solutions): reclassification to prescription-only medicine Pseudoephedrine: very rare risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) Letters and medicine recalls sent [...]

The post MHRA Drug Safety Update: February 2024 appeared first on Community Pharmacy England.